semaglutide and alzheimer's Focus: After weight loss, may be next frontier for drugs like Ozempic Alzheimer's disease: Semaglutide use linked

Statins lower your bodys GLP-1 levels By naturopath Margaret Jasinska Did you know the most commonly prescribed cholesterol lowering drugs reduce your bodys GLP-1 level by up to 50%

Continue your journey with these related reads from across pharmaphorum Click on either of the images below for more articles from this edition of Deep Dive: GLP-1 2026

FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) Description of outbreaks of healthcare associated infections related to compounding pharmacies, 2000-2012, American Journal of Health-System Pharmacy (2014) Compounding and the FDA: Questions and answers, Food and Drug Administration (2024) FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

[DOI] [PMC free article] [PubMed] [Google Scholar] Zhao F

A spokesperson for Hims and Hers declined to comment

Key Takeaway: The SELECT trial (Lincoff et al